![]() |
市場調查報告書
商品編碼
2035302
合益素飲料市場預測至2034年-按產品類型、成分類型、配方、健康益處、銷售模式、最終用戶和地區分類的全球分析Synbiotic Beverage Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Type, Formulation, Health Benefit, Sales Model, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球合益素飲料市場規模將達到 68 億美元,並在預測期內以 17.3% 的複合年成長率成長,到 2034 年將達到 244 億美元。
合益素飲料是指將益生菌活性菌叢與益生元膳食纖維、寡醣和草本添加劑結合的機能飲料產品。這些成分能夠選擇性地促進和支持特定有益益生菌在消化道內的定植,從而比單獨使用益生菌或益生元更能改善腸道健康。益生菌飲料涵蓋多種類型,例如乳製品飲料、植物來源、發酵飲料、功能性水、冰沙和果汁。
合益素的科學鑑別
越來越多的同行評審臨床研究表明,與單獨補充益生菌或益生元相比,合益素在改善腸道菌群多樣性、增強免疫功能和減輕胃腸道症狀方面效果更佳,為合生元飲料提供了強力的科學依據。這項科學依據使合益素飲料品牌能夠透過支持其卓越功效的說法,與現有的僅含益生菌的競爭對手區分開來。此外,合生元飲料還為其高價定價、獲得醫療保健專業人員的推薦和支持創造了管道,而這些在缺乏充分臨床證據的僅含益生菌的配方中是無法實現的。
與益生菌和益生元相容性相關的配方
選擇彼此具有特異性相容性的益生菌菌株和益生元底物的組合,確保益生元化合物能夠選擇性地滋養目標益生菌,而不會無意中刺激競爭性的、無益的微生物基材,這在技術上對專門的合生合益素配方提出了科學要求,遠超傳統益生菌飲料的開發能力。因此,只有少數品牌能夠生產真正有科學依據的合益素配方,從而與那些僅僅隨意組合成分、以市場行銷主導的合益素產品區分開來。
特異性疾病的優質合益素配方
針對大腸激躁症、發炎性腸道疾病緩解期、抗生素相關腹瀉、新冠肺炎後腸道菌叢失衡等疾病特異性合益素飲料配方的研發,代表著高階臨床市場的巨大機會。這使得合益素飲料品牌能夠獲得腸胃科醫生和全科醫生的推薦,而針對特異性疾病的臨床證據能夠提升專家推薦的可信度,從而使其定價遠高於一般健康腸道飲料。
發酵食品對天然合益素的競爭
消費者對天然合益素食品的組合越來越感興趣,例如Kefir、添加益生元的康普茶和發酵蔬菜製品。這些食品透過傳統的飲食習慣提供熟悉且易於接受的合益素營養,正逐漸成為配方合益素飲料的有力競爭者,尤其是在那些認為傳統發酵食品優於使用分離益生菌菌株或純化益生基材製成的功能性合益素飲料的天然飲食文化消費者中。
新冠疫情引發的免疫健康投資激增,催生了消費者對腸道健康產品前所未有的需求,直接推動了合益素飲料的快速試飲和普及。消費者希望獲得比傳統益生菌優格更科學、更先進的腸道菌叢支持。疫情後時代,人們對腸道健康的持續關注、科學媒體對腸道-免疫軸研究的報道增多,以及醫療專業人員擴大採用腸道菌群檢測,都持續推動著全球消費者對循證合益素飲料產品的需求。
在預測期內,冰沙和果汁細分市場預計將佔據最大的市場佔有率。
在預測期內,果昔和果汁預計將佔據最大的市場佔有率。這是因為,除了在機能飲料品類中擁有最高的消費頻率和購買量外,果昔和果汁也是將合益素成分融入果蔬飲料基質中最便捷的形式。水果的天然甜味和果昔熟悉的飲用體驗可以掩蓋益生菌的味道和益生元纖維的口感,從而使其更容易被普通消費者接受,而不僅僅是那些購買腸道健康補充劑的人群。
預計益生菌產業在預測期內將呈現最高的複合年成長率。
在預測期內,益生菌細分市場預計將呈現最高的成長率。這主要得益於持續的科研投入,旨在鑑定具有特定健康益處的、經臨床檢驗的益生菌菌株,從而促使消費者在原料層面要求提供檢驗合益素飲料中已驗證菌株的資訊。此外,益生菌技術的進步也推動了這一趨勢,使得穩定、高活性的益生菌培養物能夠融入各種飲料形式中。在此之前,由於加工和保存期限方面的挑戰,維持這些飲料中益生菌的活性一直是個難題。
在預測期內,北美預計將佔據最大的市場佔有率。這主要歸功於美國已建立的成熟益生菌飲料市場,以及Lifeway Foods、YAKULT和KeVita等領先的合益素飲料公司在國內市場的顯著銷售額。此外,消費者對腸道健康投資的認知度較高,以及完善的天然食品零售基礎設施為高階合益素飲料品牌的銷售和消費者教育提供了有力支持。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這是因為YAKULT在日本擁有根深蒂固的益生菌飲料文化,而日本是世界上人均益生菌飲料消費量最高的國家,這為合益素產品的市場定位提供了天然基礎;腸道健康補充劑和機能性食品在中國、韓國和澳大利亞的普及速度正在迅速成長;此外,國內益生菌飲料行業正不斷發展,將益生合益素纖維組合融入其中,從而催生出具有競爭力。
According to Stratistics MRC, the Global Synbiotic Beverage Market is accounted for $6.8 billion in 2026 and is expected to reach $24.4 billion by 2034 growing at a CAGR of 17.3% during the forecast period. Synbiotic beverages refer to functional drink products combining probiotic live bacterial cultures with prebiotic fiber, oligosaccharide, and herbal additive substrates that selectively nourish and support colonization of specific beneficial probiotic species within the gastrointestinal tract, delivering amplified gut health outcomes versus probiotic-only or prebiotic-only beverage alternatives through synergistic combined action across dairy-based, plant-based, fermented drink, functional water, and smoothie and juice beverage format categories.
Synbiotic Scientific Evidence Differentiation
Expanding peer-reviewed clinical research demonstrating superior gut microbiome diversity improvement, immune function enhancement, and digestive symptom reduction outcomes from combined synbiotic interventions versus isolated probiotic or prebiotic supplementation is creating strong scientific evidence foundation that enables synbiotic beverage brands to differentiate from established probiotic-only competitors through superior efficacy claim substantiation, justifying premium pricing and generating healthcare professional recommendation endorsement channels absent for less clinically substantiated probiotic-only formulations.
Probiotic Prebiotic Compatibility Formulation
Technical formulation complexity of selecting specifically compatible probiotic strain and prebiotic substrate pairings where prebiotic compounds selectively nourish target probiotic species without inadvertently stimulating competing non-beneficial microorganism populations creates specialized synbiotic formulation science requirements exceeding conventional probiotic beverage development competency, limiting the number of brands capable of producing genuinely evidence-based synbiotic formulations versus marketing-driven synbiotic claim products combining randomly paired ingredients.
Condition-Specific Synbiotic Formulation Premium
Development of condition-specific synbiotic beverage formulations targeting irritable bowel syndrome, inflammatory bowel disease remission maintenance, antibiotic-associated diarrhea prevention, and post-COVID gut dysbiosis recovery represents a premium clinical market opportunity enabling synbiotic beverage brands to access gastroenterologist and general practitioner recommendation channels where documented condition-specific clinical evidence generates professional recommendation credibility supporting premium pricing substantially above general wellness gut health beverage positioning.
Fermented Food Natural Synbiotic Competition
Growing consumer awareness of naturally occurring synbiotic food combinations including kefir, kombucha with prebiotic additions, and fermented vegetable preparations offering accessible and culturally familiar synbiotic nutrition through traditional food consumption represents a competitive alternative to formulated synbiotic beverage products, particularly among natural food culture consumers who perceive traditionally fermented food sources as superior to manufactured functional synbiotic beverage formulations using isolated probiotic cultures and purified prebiotic substrates.
COVID-19 immune health investment surge generating unprecedented consumer demand for gut health products directly drove rapid trial and adoption of synbiotic beverage formats as consumers sought scientifically advanced gut microbiome support beyond conventional probiotic yogurt categories. Post-pandemic sustained gut health consciousness, growing scientific media coverage of gut-immune axis research, and expanding healthcare provider gut microbiome testing adoption continue generating consumer demand for evidence-based synbiotic beverage products globally.
The smoothies & juices segment is expected to be the largest during the forecast period
The smoothies & juices segment is expected to account for the largest market share during the forecast period, due to the highest consumer consumption frequency and purchase volume within the functional beverage category combined with the most accessible format for synbiotic ingredient incorporation within fruit and vegetable beverage matrices that mask probiotic culture flavors and prebiotic fiber textures through natural fruit sweetness and familiar smoothie consumption occasions, enabling mainstream consumer adoption beyond dedicated gut health supplement purchaser demographics.
The probiotics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the probiotics segment is predicted to witness the highest growth rate, driven by continued scientific research investment identifying specific clinically validated probiotic strains for targeted health outcome applications generating ingredient-level consumer demand for verified strain identity disclosure in synbiotic beverages, combined with probiotic technology advancement enabling stable high-viability probiotic culture incorporation in diverse beverage formats that previously compromised live culture count maintenance through processing and shelf life challenges.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting a well-established probiotic beverage market with leading synbiotic beverage companies including Lifeway Foods, Yakult, and KeVita generating substantial domestic revenue, strong consumer gut health investment culture, and extensive natural food retail infrastructure supporting premium synbiotic beverage brand distribution and consumer education.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to Japan hosting Yakult's deeply embedded probiotic beverage culture with the world's highest per-capita probiotic drink consumption providing natural advancement foundation for synbiotic positioning, rapidly growing gut health supplement and functional food adoption across China, South Korea, and Australia, and domestic probiotic beverage industry development incorporating prebiotic fiber combinations to create regionally competitive synbiotic beverage innovation.
Key players in the market
Some of the key players in Synbiotic Beverage Market include Danone S.A., Nestle S.A., PepsiCo Inc., The Coca-Cola Company, Yakult Honsha Co. Ltd., Lifeway Foods Inc., General Mills Inc., Chobani LLC, KeVita (PepsiCo), GoodBelly (NextFoods), Biotiful Dairy, Inner Health Plus, Probi AB, Nestle Health Science, Arla Foods, Fonterra Co-operative Group, and Valio Ltd..
In April 2026, Lifeway Foods Inc. launched a new synbiotic kefir smoothie collection combining 12 live probiotic strains with certified organic prebiotic inulin fiber targeting clinical GI health positioning with registered dietitian endorsement program support.
In March 2026, KeVita (PepsiCo) introduced a plant-based synbiotic sparkling water range with added prebiotic galactooligosaccharides and Bacillus coagulans probiotic targeting mainstream US retail distribution with ambient shelf-stable convenient synbiotic positioning.
In December 2025, GoodBelly (NextFoods) expanded its clinically studied probiotic beverage portfolio with a new synbiotic juice shot range incorporating Jerusalem artichoke prebiotic extract with Lactobacillus plantarum targeting daily gut health maintenance consumers.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.